{
    "2021-04-15": [
        [
            {
                "time": "",
                "original_text": "306家药企晒2020成绩单！超40家亏损，77家翻倍，云南白药、复星……狂赚超30亿",
                "features": {
                    "keywords": [
                        "药企",
                        "2020成绩单",
                        "亏损",
                        "翻倍",
                        "云南白药",
                        "复星"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "4月15日，ST舍得股价突破100元，成为A股史上首支突破百元的ST股。",
                "features": {
                    "keywords": [
                        "ST舍得",
                        "股价突破",
                        "百元",
                        "A股史上首支"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股首只！“ST”百元股来了，ST舍得拔得头筹，行业普遍回调，为何它一枝独秀？",
                "features": {
                    "keywords": [
                        "A股",
                        "ST百元股",
                        "ST舍得",
                        "行业回调"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "晚间重要公告2021年4月15日星期四",
                "features": {
                    "keywords": [
                        "晚间公告",
                        "2021年4月15日"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "速读社丨澳门特区政府暂缓阿斯利康疫苗供澳 科伦药业罗红霉素片首家过评",
                "features": {
                    "keywords": [
                        "澳门特区政府",
                        "阿斯利康疫苗",
                        "科伦药业",
                        "罗红霉素片"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "创新时代，这些药企研发费用大增",
                "features": {
                    "keywords": [
                        "创新时代",
                        "药企",
                        "研发费用",
                        "大增"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(600196.SH)：用于实体瘤及淋巴瘤治疗的HLX26获批准开展临床试验",
                "features": {
                    "keywords": [
                        "复星医药",
                        "实体瘤",
                        "淋巴瘤",
                        "HLX26",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(600196.SH)控股子公司重组抗LAG-3人源化单克隆抗体注射液获临床试验批准",
                "features": {
                    "keywords": [
                        "复星医药",
                        "重组抗LAG-3",
                        "单克隆抗体",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "四个交易日翻倍！一季报“预增王”股价站上百元关口下一个是谁？",
                "features": {
                    "keywords": [
                        "交易日翻倍",
                        "一季报",
                        "预增王",
                        "股价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股217家药企发布年报，多家药企研发费用增长明显",
                "features": {
                    "keywords": [
                        "A股",
                        "药企",
                        "年报",
                        "研发费用",
                        "增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "越跌越买！一周内私募举牌两家A股，释放什么信号？",
                "features": {
                    "keywords": [
                        "越跌越买",
                        "私募举牌",
                        "A股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}